Literature DB >> 12941683

Psychopharmacological treatment of major depressive disorder in children and adolescents.

Christopher K Varley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941683     DOI: 10.1001/jama.290.8.1091

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  Efficacy and safety of antidepressants for children and adolescents.

Authors:  Jon N Jureidini; Christopher J Doecke; Peter R Mansfield; Michelle M Haby; David B Menkes; Anne L Tonkin
Journal:  BMJ       Date:  2004-04-10

Review 2.  Treating depression in children and adolescents: what options now?

Authors:  Christopher K Varley
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  US suicide rates by age group, 1970-2002: an examination of recent trends.

Authors:  Robert E McKeown; Steven P Cuffe; Richard M Schulz
Journal:  Am J Public Health       Date:  2006-10       Impact factor: 9.308

4.  Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults.

Authors:  L Charles Murrin; Jeff D Sanders; David B Bylund
Journal:  Biochem Pharmacol       Date:  2007-01-25       Impact factor: 5.858

5.  Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development.

Authors:  J D Sanders; H K Happe; D B Bylund; L C Murrin
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

6.  Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.

Authors:  Robert J Valuck; Anne M Libby; Marion R Sills; Alexis A Giese; Richard R Allen
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.